 | Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | |
 | Out- side |
| | | | |
|
| | | | |
Result : Searchterm 'Dotarem' found in 1 term [ ] and 6 definitions [ ]
| 1 - 5 (of 7) nextResult Pages : [1] [2] | |  | |
 |
Searchterm 'Dotarem'
was also found in the following service of MR-TIP.com: |
|
| | | |  |  |
| Dotarem® |   |
| |
|
Dotarem® is a paramagnetic ionic MRI contrast agent. Extracellular contrast agents like Dotarem®, can be bolus injected because of the relatively low rate of side effects. This contrast medium is useable to enhance signal intensity in magnetic resonance imaging for intracranial and spinal lesions with an abnormal blood brain barrier or abnormal vascularity, and in whole body imaging.
|
|
Drug Information and Specification |
| NAME OF COMPOUND |
Gadoterate meglumine, Gd-DOTA |
| DEVELOPER |
Guerbet S.A. |
| CENTRAL MOIETY |
Gd2+ |
| CONTRAST EFFECT |
T1, Predominantly positive enhancement |
| RELAXIVITY |
r1=3.4, r2=4.8, B0=1.0T |
| PHARMACOKINETIC |
Intravascular, extracellular, renal excretion |
| OSMOLALITY |
1350 mosm/kgH2O |
| CONCENTRATION |
0.5 mol/L |
| DOSAGE |
0.1 mmol/kg / 0.2mL/kg |
| PREPARATION |
Finished product |
| INDICATION |
Neuro/whole body |
| DEVELOPMENT STAGE |
For sale |
| DISTRIBUTOR |
See below |
| PRESENTATION |
Vials of 5, 10, 15, 20mL Pre-filled syringes of 15 and 20 mL |
| DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT! |
|
|
Distribution Information |
| TERRITORY |
TRADE NAME |
DEVELOPMENT STAGE |
DISTRIBUTOR |
| EU |
Dotarem® |
for sale |
Guerbet S.A. |
| France, Switzerland |
Artirem® |
for sale |
Guerbet S.A. |
| Australia |
Dotarem® |
for sale |
|
|
| |  | |
Further Reading: |
Basics:
|
|
News & More:
| | | | |
|  |
 |
MRI Resources |
|
| | | |  |  |  |
| Artirem® |   |
| |
|
Artirem®, the arthrography-specific contrast agent for MRI is a dilute form of Dotarem® with a less concentration of Gd (1:200).
Artirem® has to be injected directly into the joints for better visualisation and delimitation, of the ligament and tendon structures in particular.
|
|
Drug Information and Specification |
| NAME OF COMPOUND |
Gadoterate meglumine, Gd-DOTA |
| DEVELOPER |
Guerbet S.A. |
| CENTRAL MOIETY |
Gd2+ |
| CONTRAST EFFECT |
T1, Predominantly positive enhancement |
| RELAXIVITY |
r1=3.4, r2=4.8, B0=1.0T |
| PHARMACOKINETIC |
Intravascular, extracellular, renal excretion |
| CONCENTRATION |
0,0025 mmol/ml |
| PREPARATION |
Finished product |
| INDICATION |
Arthrography |
| DEVELOPMENT STAGE |
For sale |
| DISTRIBUTOR |
See below |
| PRESENTATION |
Pre-filled syringes of 20 mL |
| DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT! |
|
|
| |  | | | |
|  |
 |
Searchterm 'Dotarem'
was also found in the following service of MR-TIP.com: |
|
| | | |
|
 |  |
| |
|
The France-based Guerbet Group is highly specialized in contrast media for medical imaging. Its strategic goal is to be a key player in this market. Products include Dotarem (Magnetic Resonance Imaging) and Xenetix (X-ray Imaging).
|
|
|
Contact Information |
| MAIL |
Guerbet
Boite postale 50400
95943 Roissy
Charles de Gaulle Cedex
FRANCE |
| PHONE |
+33-1-45-91-50-00 |
| FAX |
+33-1-45-91-51-99 |
| ONLINE |
www.guerbet.com |
|
| |  | |
Further Reading: |
News & More:
|
| | | | •• There are 2 news about 'Guerbet S.A.'. | |
|  |
 |
MRI Resources |
|
| | | |  |  |  |
| Extracellular Fluid Agents |   |
| |
|
| |  | | | |
|  |
 |
Searchterm 'Dotarem'
was also found in the following service of MR-TIP.com: |
|
| | | |
|
 |  |
| Gadolinium |   |
| |
|
(Gd) Gadolinium is a Lanthanide element that is paramagnetic in its trivalent state.
This paramagnetic substance is used for MR imaging because of the effect of strongly decreasing the T1 relaxation times of the tissues to which gadolinium has access. When injected during magnetic resonance imaging, gadolinium will tend to change signal intensities by shortening the T1 time in its surroundings.
The relaxivity of gadolinium is an important measure of its efficacy, which is dependend on the chemical properties of the complex. The gadolinium ion cannot be used in its chloride, sulfate, or acetate forms because of poor tolerance and low solubility in water in the neutral pH range. Although toxic by itself, gadolinium can be given safely in a chelated form such as DTPA, that still retains much of its strong effect on relaxation times (relaxivity).
See also Dotarem®, Gadovist®, MultiHance®, Omniscan®, OptiMARK®, and Contrast Agents, the info sheet gives an overview and more in-dept information about different types of MRI contrast agents. |
| | | |  | |
Further Reading: |
Basics:
|
|
News & More:
| | | | | •• There are 17 news about 'Gadolinium'. | |
|  |
|
 |
MRI Resources |
|
| | | |  |  | 1 - 5 (of 7) nextResult Pages : [1] [2] |
| |
|
| |
 | Look Ups |
| |